NASDAQ:CVRX

Cvrx Stock Insider Trading

Healthcare > Medical - Devices

Buy CVRX

*Your capital is at risk

$5.15

+0.290 (+5.97%)

At Close: Jun 23, 2026

CVRx Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 70.69. In total, the insiders bought 3.49M and sold 100.92K CVRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	70.69
● Buy	3.49M shares
● Sell	100.92K shares
87% Buy Activity Weak Positive Correlation
Buy Signal High Confidence Feb 27, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 70.69. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (87% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 27, 2026 Buy	Stock Option (right to buy) A-Award	Binkowski Brent Chief Operating Officer	C-Suite Officer	23 000 Value: $187.7K
Feb 27, 2026 Buy	Stock Option (right to buy) A-Award	John Robert Allen Chief Revenue Officer	Officer	52 000 Value: $424.3K
Feb 27, 2026 Buy	Stock Option (right to buy) A-Award	Oasheim Jared Chief Financial Officer	C-Suite Officer	91 000 Value: $742.6K
Feb 27, 2026 Buy	Common Stock A-Award	Hykes Kevin Pres & CEO	CEO / President	159 000 Value: $1.30M
Feb 27, 2026 Buy	Stock Option (right to buy) A-Award	Hykes Kevin Pres & CEO	CEO / President	238 000 Value: $1.94M
Feb 27, 2026 Buy	Stock Option (right to buy) A-Award	Verrastro Paul Chief Mktg & Strat Officer	Officer	67 000 Value: $546.7K
Feb 27, 2026 Buy	Common Stock A-Award	Verrastro Paul Chief Mktg & Strat Officer	Officer	45 000 Value: $367.2K
Feb 27, 2026 Buy	Common Stock A-Award	Oasheim Jared Chief Financial Officer	C-Suite Officer	61 000 Value: $497.8K
Feb 27, 2026 Buy	Common Stock A-Award	John Robert Allen Chief Revenue Officer	Officer	35 000 Value: $285.6K
Feb 27, 2026 Buy	Common Stock A-Award	Binkowski Brent Chief Operating Officer	C-Suite Officer	15 000 Value: $122.4K
Feb 20, 2026 Buy	Common Stock P-Purchase	Jain Mudit K. Director	Director	46 800 Value: $297.6K
Feb 18, 2026 Buy	Common Stock P-Purchase	Jain Mudit K. Director	Director	600 Value: $3K
Nov 26, 2025 Sell	Common Stock S-Sale	Johnson & Johnson 10 Percent Owner	10% Owner	6 337 Value: $63.6K
Nov 26, 2025 Sell	Common Stock S-Sale	Johnson & Johnson 10 Percent Owner	10% Owner	6 337 Value: $63.6K
Nov 25, 2025 Sell	Common Stock S-Sale	Johnson & Johnson 10 Percent Owner	10% Owner	16 000 Value: $160.5K
Nov 24, 2025 Sell	Common Stock S-Sale	Johnson & Johnson 10 Percent Owner	10% Owner	2 200 Value: $22.1K
Nov 21, 2025 Sell	Common Stock S-Sale	Johnson & Johnson 10 Percent Owner	10% Owner	500 Value: $5K
Nov 12, 2025 Sell	Common Stock S-Sale	Johnson & Johnson 10 Percent Owner	10% Owner	1 000 Value: $10.0K
Nov 07, 2025 Sell	Common Stock S-Sale	Johnson & Johnson 10 Percent Owner	10% Owner	200 Value: $2K
Nov 06, 2025 Sell	Common Stock S-Sale	Johnson & Johnson 10 Percent Owner	10% Owner	52 332 Value: $534.3K
Aug 11, 2025 Buy	Stock Option (right to buy) A-Award	Binkowski Brent Chief Operating Officer	C-Suite Officer	74 900 Value: $562.5K
Aug 11, 2025 Buy	Common Stock A-Award	Binkowski Brent Chief Operating Officer	C-Suite Officer	16 600 Value: $124.7K
Aug 11, 2025 Buy	Common Stock J-Other	Binkowski Brent Insider	Other	0 Value: $0
Aug 11, 2025 Buy	Common Stock J-Other	Binkowski Brent Insider	Other	0 Value: $0
Aug 11, 2025 Buy	Common Stock A-Award	Binkowski Brent Chief Operating Officer	C-Suite Officer	16 600 Value: $124.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CVRX, INC.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributo...

Read Full Profile Here